Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    AZD-3043

    go.drugbank.com/drugs/DB12576
    Investigational

    AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.

  2. Drug

    JNJ-41443532

    go.drugbank.com/drugs/DB12632
    Investigational

    JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.

  3. Drug

    Samalizumab

    go.drugbank.com/drugs/DB12636
    Investigational

    Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.

  4. Drug

    Nelivaptan

    go.drugbank.com/drugs/DB12643
    Investigational

    Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.

  5. Drug

    GS-9256

    go.drugbank.com/drugs/DB12876
    Investigational

    GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

  6. Drug

    VTP-194204

    go.drugbank.com/drugs/DB11806
    Investigational

    Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.

  7. Drug

    Prothipendyl

    go.drugbank.com/drugs/DB12958
    Investigational

    Prothipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.

  8. Drug

    N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide

    go.drugbank.com/drugs/DB03456
    Experimental

    This compound belongs to the n-acyl-alpha amino acids and derivatives. … These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. It is known to target cathepsin K.

  9. Drug

    Gevokizumab

    go.drugbank.com/drugs/DB12119
    Investigational

    Gevokizumab has been used in trials studying the treatment of Acne Vulgaris, Osteoarthritis, Behcet's Uveitis, Pyoderma Gangrenosum, and Behcet's Disease Uveitis, among others. … Gevokizumab acts as a modulator of cytokine imbalance in IL-1 mediated disease states. It has a very high binding affinity of 300fM and blocks the activation of IL-1 receptors.

  10. Drug

    FINLAY-FR-1

    go.drugbank.com/drugs/DB16524
    Experimental

    , of the prophylactic FINLAY-FR-1 anti-SARS-CoV-2 Vaccine Candidate in a two-doses schedule. … It is currently being tested in the clinical trial RPCEC00000332 (Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity